Press release
Growth Dynamics on Retinal Disease Therapeutics Market 2018-2026| Key Players: Merck & Co., Inc., Novartis AG and More
Sample PDF Brochure:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/retinal-disease-therapeutics-market-100311
F. Hoffmann-La Roche AG’s ‘Lucentis’ is Gaining Increasing Popularity
The global retinal disease therapeutics market is consolidated in nature, with only a handful of market players accounting for maximum share of the market. With consolidation, it is becoming increasingly difficult for newer market entrants to establish a stronghold or derive immediate success.Therefore the global market is boosted by products and concepts introduced by existing companies.
One such instance of this development is the “Lucentis” therapy, put forward by F. Hoffmann-La Roche AG. Lucentis was introduced with an aim of providing therapeutic advice and development of products for patients suffering from chronic disease. In 2017, the Food and Drug Administration (FDA) approved Lucentis for diabetic retinopathy. The diabetic retinopathy is a severe kind of disorder that has accounted for majority of cases of blindness in the US. Lucentis was an instant hit among healthcare professionals, after it was backed by a series of clinical trials and aprovals from the National Institute of Health (NIH).
Excellent clinical effects of Lucentis have led to a subsequent rise in demand for the medicine among patients. The increasing demand has contributed to the growth of the global retinal disease therapeutics market and is likely to favor the market in the forthcoming years.
North America to Emerge Dominant in the Forecast Period
The increasing government investment towards research and development of retinal disease drugs and diagnostic devices is enabling growth in the retinal diseases therapeutics market in North America. North America has emerged dominant in the global retinal disease therapeutics market in recent years. The retinal disease therapeutics market in North America was valued at US$ 4056.5Mn in 2018 and is likely to increase in the coming years.
Improved health infrastructures, increasing patient pool, and favourable health reimbursement policies are some of the factors that are likely to boost the regional market in the forthcoming years. High prevalence of retinal diseases in Asia Pacific is a major reason, why this region is estimated to rise with the highest CAGR in the forecast period.
Some of the leading companies that are operating in the global retinal disease therapeutics market are Merck & Co., Inc., Novartis AG, Allergan plc, F. Hoffmann-La Roche AG, Regeneron Pharmaceuticals, Inc., and Santen Pharmaceutical Co., Ltd.
Browse Complete Report Details:
https://www.fortunebusinessinsights.com/industry-reports/retinal-disease-therapeutics-market-100311
Contact Us:
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Growth Dynamics on Retinal Disease Therapeutics Market 2018-2026| Key Players: Merck & Co., Inc., Novartis AG and More here
News-ID: 1777793 • Views: …
More Releases from Fortune Business Insights
Future of Renewable Energy Market Insights: Growth Drivers, and Regional Develop …
Global Renewable Energy Market Overview
The global renewable energy market size was valued at USD 954 billion in 2023. The market is projected to grow from USD 1,020.94 billion in 2024 to USD 1,574.17 billion by 2032, exhibiting a CAGR of 5.56% during the forecast period. Asia Pacific dominated the renewable energy market with a market share of 67.76% in 2023. The Renewable energy market in the U.S. is projected to…
DC Drives Market Overview: Opportunities, Growth Drivers, and Key Applications
Market Overview
The global DC drives market size was valued at USD 4.34 billion in 2018 and is projected to reach USD 9.23 billion by 2032, exhibiting a CAGR of 5.59% during the forecast period of 2019-2032. Asia Pacific dominated the global market with a share of 28.8% in 2018. The DC drives market in the U.S. is projected to grow significantly, reaching an estimated value of USD 1.59 billion by…
Humanoid Robots Market: An In-depth B2B Analysis of Size, Share, and Future Grow …
Brief Market Overview:
The global humanoid robots market is rapidly transitioning from a nascent field into a major growth sector, with its value escalating from USD 2.43 billion in 2023 to a projected USD 66.0 billion by 2032, demonstrating a remarkable CAGR of 45.5%.
These complex machines, which merge mechanical, electrical, and software engineering, are moving beyond research labs into real-world applications across industrial, service, and household sectors. This explosive growth…
Methanol Market Poised for Remarkable Growth, set to Reach USD 46.32 billion by …
The global methanol market size was valued at USD 31.26 billion in 2023. It is projected to grow from USD 32.70 billion in 2024 to USD 46.32 billion by 2032, exhibiting a CAGR of 4.5% during the forecast period.
The global methanol market size is set to gain traction from the urgent need to lower environmental pollution caused by the surging usage of heavy fuels, such as diesel and gasoline. Pollution…
More Releases for Lucentis
Exclusive Lucentis Market Report with In-Depth Study Analysis by 2025-2032 | Fea …
The latest report titled Lucentis Market Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032. offering a comprehensive and in-depth analysis of the industry. The report provides key insights into current market trends, growth drivers, challenges, and opportunities shaping the market landscape. It also includes a thorough competitor analysis, regional market evaluation, and recent technological or strategic developments influencing the market trajectory.
Currently, the Lucentis market holds a strong global presence. The…
Lucentis Market Surging with Biosimilar Entry and Rising Prevalence of Retinal D …
The Global Lucentis Market is estimated to be valued at USD 739.1 Mn in 2025 and is expected to reach USD 64.1 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of -29.5% from 2025 to 2032.
The latest Lucentis Market research report offers crucial insights into how the industry is evolving, highlighting key drivers of growth and the main revenue streams expected between 2025 and 2032. It analyzes…
Lucentis (Ranibizumab) Industry Report 2025-2034: Market Dynamics, Trends, And F …
The Lucentis (Ranibizumab) Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Lucentis (Ranibizumab) Market?
The market size of lucentis (ranibizumab) has seen considerable growth of late. The market is projected to expand from $3,538.57 million in 2024 to $3,741.97…
Lucentis (Ranibizumab) Market Forecast 2025-2034: Evaluating Growth Factors, Seg …
What industry-specific factors are fueling the growth of the lucentis (ranibizumab) market?
An increase in eye-related disorders, such as those caused by aging, genetics, poor lifestyle choices, and environmental factors, is expected to propel the Lucentis (ranibizumab) market's growth. These disorders impair the eyes' functionality, and Lucentis has shown to be an effective treatment by blocking vascular endothelial growth factor (VEGF), a protein that leads to abnormal blood vessel growth and…
Lucentis (Ranibizumab) Market Forecast 2025-2034: Evaluating Growth Factors, Seg …
What industry-specific factors are fueling the growth of the lucentis (ranibizumab) market?
An increase in eye-related disorders, such as those caused by aging, genetics, poor lifestyle choices, and environmental factors, is expected to propel the Lucentis (ranibizumab) market's growth. These disorders impair the eyes' functionality, and Lucentis has shown to be an effective treatment by blocking vascular endothelial growth factor (VEGF), a protein that leads to abnormal blood vessel growth and…
A Deep Dive into Lucentis (Ranibizumab) Market 2025: Key Drivers, Growth Factors …
What Is the Expected Size and Growth Rate of the Lucentis (Ranibizumab) Market?_x000D_
In recent years, the market size for Lucentis (ranibizumab) has seen a robust growth. Projected to increase from $3,538.57 million in 2024 to $3,741.97 million in 2025, this market will reportedly grow at a compound annual growth rate (CAGR) of 5.7%. The surge in growth during the historical period can be ascribed to factors such as the rising…
